MindMed’s Nasdaq Debut a Win for Alternative Medicine. Is It a Buy?

Is your money at stake??

Published: April 29, 2021 Trade Like a Wall Street Insider Ever wonder why Wall Street always seems to be one step ahead of the average Joe? It's because insiders have a ton of top-secret trading strategies that give them an edge over everyone else! And while their methods are usually kept under lock and key… I'm using what I learned as a former hedge fund insider to pull back the curtain on Wall Street's best kept market strategy. I'm ready to reveal how tracking what I call a "Shadow Blitz" can help everyday traders predict which stocks are set to explode… See How To Use This Discovery Lance Ippolito Lance is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. MindMed's Nasdaq Debut a Win for Alternative Medicine. Is It a Buy? Alternative drug developer Mind Medicine Inc. (Nasdaq: MNMD) debuted on the Nasdaq on Tuesday following an incredible two-day run-up that saw the stock jump over 47%. MindMed is a biotechnology company focused on the clinical development of psychedelic-sourced drugs. This is a big win for the alternative pharmaceutical space after years of struggling for mainstream recognition. The medical and business communities are beginning to realize that treatments like psilocybin mushrooms, ketamine and DMT can help with mental disorders like anxiety, depression and trauma. According to the Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults. Here's Why I'm Excited Russell 2000 Forecast and the 5 Stocks to Target April 26, 2021 A little while ago WealthPress Senior Strategist Roger Scott filmed a Russell 2000 forecast video, and explained how it was beginning to come back to life... Continue Reading How to Play Tesla — or Any — Earnings With Limited Risk April 26, 2021 When implied volatility picks up the way it does around earnings events, it offers traders the opportunity to take advantage of it if they know how... Continue Reading A New Money Crew Publication Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.  Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.  Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions. This email was sent to phanhoa1821960.trader@blogger.com by WealthPress LLC 495 Town Plaza Ave | | Jacksonville | FL | 32081 Forward to a friend | Unsubscribe From All WealthPress Emails